Literature DB >> 18614618

Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells.

Sanjai K Addla1, Mick D Brown, Claire A Hart, Vijay A C Ramani, Noel W Clarke.   

Abstract

The fundamental changes which predispose for renal cell carcinoma (RCC) are poorly characterized. It is hypothesized that "cancer stem cells" may be influential in carcinogenesis, and the epithelial side population (SP) is enriched for stemlike cells in other epithelial cancers. In this study, we have isolated and characterized the SP and non-SP (NSP) populations from normal (NK) and malignant (RCC) human kidney tissue. NK specimens were taken from patients undergoing non-renal cancer surgery and paired malignant and macroscopically normal tissue samples were taken from patients undergoing surgery for RCC. The Hoechst 33342 dye efflux technique was used to isolate epithelial SP and NSP from normal and malignant human renal tissue. Cellular subpopulations were phenotyped for lineage, cell cycle, and putative stem cell markers, and functionally characterized using in vitro colony-forming and proliferation assays. The SP constituted 3.8 +/- 0.4 and 5.9 +/- 0.9% of epithelial cells in NK and RCC, respectively, of which 14.1 +/- 3.5 and 13.2 +/- 3.6% were shown to be in G(0). SP cells demonstrated greater proliferative potential in colony-forming efficiency, long-term culture, and spheroids assays and were shown to be maintained upon tissue culture passage. We have shown that the renal SP is enriched for quiescent cells, with a high proliferative capacity and stemlike properties. The population is, however, heterogeneous, confirming that the terms "SP cell" and "stem cell" cannot be used interchangeably.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614618      PMCID: PMC2536866          DOI: 10.1152/ajprenal.90286.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  28 in total

1.  Experimental prostate epithelial morphogenesis in response to stroma and three-dimensional matrigel culture.

Authors:  S H Lang; M Stark; A Collins; A B Paul; M J Stower; N J Maitland
Journal:  Cell Growth Differ       Date:  2001-12

Review 2.  Stem cells in the kidney.

Authors:  Qais Al-Awqati; Juan A Oliver
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

Review 3.  The Hedgehog and Wnt signalling pathways in cancer.

Authors:  J Taipale; P A Beachy
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 4.  Developmental approaches to kidney tissue engineering.

Authors:  Dylan L Steer; Sanjay K Nigam
Journal:  Am J Physiol Renal Physiol       Date:  2004-01

5.  Novel method for the isolation and characterisation of the putative prostatic stem cell.

Authors:  Rupesh I Bhatt; Michael D Brown; Claire A Hart; Paul Gilmore; Vijay A C Ramani; Nicholas J George; Noel W Clarke
Journal:  Cytometry A       Date:  2003-08       Impact factor: 4.355

6.  Isolation and potential existence of side population cells in adult human kidney.

Authors:  Toshihiko Inowa; Keiichi Hishikawa; Takumi Takeuchi; Tadaichi Kitamura; Toshiro Fujita
Journal:  Int J Urol       Date:  2008-03       Impact factor: 3.369

7.  Holoprosencephaly, sacral anomalies, and situs ambiguus in an infant with partial monosomy 7q/trisomy 2p and SHH and HLXB9 haploinsufficiency..

Authors:  M J Nowaczyk; M J Huggins; D J Tomkins; E Rossi; J A Ramsay; J Woulfe; S W Scherer; E Belloni
Journal:  Clin Genet       Date:  2000-05       Impact factor: 4.438

Review 8.  The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.

Authors:  F Nollet; G Berx; F van Roy
Journal:  Mol Cell Biol Res Commun       Date:  1999-08

Review 9.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

10.  Paradoxical expression of E-cadherin in prostatic bone metastases.

Authors:  A A Bryden; A J Freemont; N W Clarke; N J George
Journal:  BJU Int       Date:  1999-12       Impact factor: 5.588

View more
  36 in total

Review 1.  Progenitor/stem cells in renal regeneration and mass lesions.

Authors:  Ping L Zhang; Jason M Hafron
Journal:  Int Urol Nephrol       Date:  2014-09-03       Impact factor: 2.370

2.  Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.

Authors:  Samriti Dogra; Sriram Bandi; Preeti Viswanathan; Sanjeev Gupta
Journal:  Cancer Lett       Date:  2014-11-10       Impact factor: 8.679

Review 3.  Ovarian cancer stem cells: elusive targets for chemotherapy.

Authors:  Achuta Kumar Guddati
Journal:  Med Oncol       Date:  2012-05-26       Impact factor: 3.064

4.  Sorting and biological characteristics analysis for side population cells in human primary hepatocellular carcinoma.

Authors:  Yegui Jiang; Hucheng Gao; Mingdong Liu; Qing Mao
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

Review 5.  CD133: to be or not to be, is this the real question?

Authors:  Elena Irollo; Giuseppe Pirozzi
Journal:  Am J Transl Res       Date:  2013-09-25       Impact factor: 4.060

Review 6.  Epigenetic gene regulation in stem cells and correlation to cancer.

Authors:  Lesley A Mathews; Francesco Crea; W L Farrar
Journal:  Differentiation       Date:  2009-05-14       Impact factor: 3.880

7.  The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer.

Authors:  Tarek M A Elsaba; Luisa Martinez-Pomares; Adrian R Robins; Simon Crook; Rashmi Seth; Darryl Jackson; Amy McCart; Andrew R Silver; Ian P M Tomlinson; Mohammad Ilyas
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population.

Authors:  M R Loebinger; E K Sage; D Davies; S M Janes
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

Review 9.  Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations.

Authors:  Rajasekharan Somasundaram; Jessie Villanueva; Meenhard Herlyn
Journal:  Adv Pharmacol       Date:  2012

10.  Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44+CD133+ subpopulation of Caco-2 cells.

Authors:  Junghoon Kim; Kyeng-Won Choi; Jungwoon Lee; Jaeyoung Lee; Seonock Lee; Ruijing Sun; Jungho Kim
Journal:  Int J Biol Sci       Date:  2021-04-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.